Hinge Health (HNGE) Gains from Sales and Divestitures (2025)
Hinge Health's (HNGE) quarterly Gains from Sales and Divestitures came in at $844426.0 in Q3 2025, up 178.11% quarter-over-quarter from $303634.0 in Q2 2025.
Hinge Health (HNGE) Gains from Sales and Divestitures (2025) Analysis & Trends
Hinge Health has disclosed Gains from Sales and Divestitures across 1 years of filings, most recently posting $844426.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn |
| 10 | Teladoc Health | 1.31 Bn | 562.23 Mn | 562.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 844,426.00 |
| Sep 30, 2025 | 844,426.00 |
| Jun 30, 2025 | 303,634.00 |
| Jun 30, 2025 | 303,634.00 |